Screened selection design for randomised phase II oncology trials: an example in chronic lymphocytic leukaemia

Mostrar otras versiones (1)

BACKGROUND: As there are limited patients for chronic lymphocytic leukaemia trials, it is important that statistical methodologies in Phase II efficiently select regimens for subsequent evaluation in larger-scale Phase III trials. METHODS: We propose the screened selection design (SSD), which is a p...

Descripción completa

Detalles Bibliográficos
Autores principales: Yap, Christina, Pettitt, Andrew, Billingham, Lucinda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3726070/
https://www.ncbi.nlm.nih.gov/pubmed/23819695
http://dx.doi.org/10.1186/1471-2288-13-87

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3726070/
https://www.ncbi.nlm.nih.gov/pubmed/23819695
http://dx.doi.org/10.1186/1471-2288-13-87

Ejemplares similares